Page last updated: 2024-11-06

n-nitrosobis(2-oxobutyl)amine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

n-Nitrosobis(2-oxobutyl)amine, also known as NDBA, is a potent mutagen and animal carcinogen. It is formed through the reaction of secondary amines with nitrous acid, a process that can occur in various environments such as the human stomach, during food processing, and in the environment. The compound is particularly concerning due to its presence in certain processed meats, where it arises from the reaction of nitrites used as preservatives with secondary amines in meat. NDBA has been shown to induce tumors in animal studies and is considered a probable human carcinogen by the International Agency for Research on Cancer (IARC). Its formation and presence in food products have driven extensive research efforts to understand its formation mechanisms, its effects on human health, and develop strategies to minimize its presence in food.'

N-nitrosobis(2-oxobutyl)amine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID53725
MeSH IDM0098775

Synonyms (6)

Synonym
2-butanone, 1,1'-(nitrosoimino)bis-
n-nitrosobis(2-oxobutyl)amine
ccris 3215
bis(2-oxobutyl)nitrosamine
77698-19-2
DTXSID80228321
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (57.14)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.32 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.40 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]